Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-04-07 6:23 pm Purchase | 2022-03-02 | 13G | HOOKIPA PHARMA INC HOOK | EcoR1 Capital, LLC | 509,086 9.990% | 509,086 (New Position) | Filing History |
| 2022-03-14 3:55 pm Purchase | 2022-03-11 | 13G | SURFACE ONCOLOGY INC SURF | EcoR1 Capital, LLC | 4,653,000 9.900% | 4,604,442 (+9482.36%) | Filing History |
| 2022-02-14 4:55 pm Purchase | 2022-02-04 | 13G | ALIGOS THERAPEUTICS INC ALGS | EcoR1 Capital, LLC | 128,532 7.500% | 128,532 (New Position) | Filing History |
| 2022-02-14 4:02 pm Purchase | 2021-12-31 | 13G | ARCUS BIOSCIENCES INC RCUS | EcoR1 Capital, LLC | 5,523,358 7.900% | 951,311 (+20.81%) | Filing History |
| 2022-02-14 4:01 pm Unchanged | 2021-12-31 | 13G | VOYAGER THERAPEUTICS INC VYGR | EcoR1 Capital, LLC | 3,557,507 9.400% | 0 (Unchanged) | Filing History |
| 2022-02-14 3:58 pm Purchase | 2021-12-31 | 13G | 2SEVENTY BIO INC TSVT | EcoR1 Capital, LLC | 1,917,063 8.200% | 26,400 (+1.40%) | Filing History |
| 2022-02-14 3:22 pm Sale | 2021-12-31 | 13G | SHATTUCK LABS INC STTK | EcoR1 Capital, LLC | 0 0.000% | -3,295,088 (Position Closed) | Filing History |
| 2022-02-14 3:21 pm Purchase | 2021-12-31 | 13G | ALECTOR INC ALEC | EcoR1 Capital, LLC | 4,994,970 6.100% | 252,336 (+5.32%) | Filing History |
| 2022-02-14 3:21 pm Purchase | 2021-12-31 | 13G | OVID THERAPEUTICS INC OVID | EcoR1 Capital, LLC | 6,082,200 8.900% | 6,082,200 (New Position) | Filing History |
| 2022-02-14 3:19 pm Purchase | 2021-12-31 | 13G | SOLID BIOSCIENCES INC SLDB | EcoR1 Capital, LLC | 613,513 8.300% | 81,666 (+15.36%) | Filing History |
| 2022-02-14 3:03 pm Purchase | 2021-12-31 | 13G | AVIDITY BIOSCIENCES INC RNAM | EcoR1 Capital, LLC | 2,759,505 5.900% | 655,555 (+31.16%) | Filing History |
| 2022-02-14 3:03 pm Sale | 2021-12-31 | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | EcoR1 Capital, LLC | 43,031 2.000% | -113,104 (-72.44%) | Filing History |
| 2022-02-14 3:02 pm Purchase | 2021-12-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | EcoR1 Capital, LLC | 3,468,944 8.800% | 376,726 (+12.18%) | Filing History |
| 2022-02-14 3:01 pm Purchase | 2021-12-31 | 13G | MORPHIC HLDG INC MORF | EcoR1 Capital, LLC | 3,951,566 10.700% | 1,111,682 (+39.15%) | Filing History |
| 2022-02-14 2:38 pm Unchanged | 2021-12-31 | 13G | ATRECA INC BCEL | EcoR1 Capital, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 2:17 pm Sale | 2021-12-31 | 13G | GERON CORP GERN | EcoR1 Capital, LLC | 9,615,385 2.900% | -18,939,925 (-66.33%) | Filing History |
| 2022-02-14 2:16 pm Sale | 2021-12-31 | 13G | ATRECA INC BCEL | EcoR1 Capital, LLC | 0 0.000% | -2,426,685 (Position Closed) | Filing History |
| 2022-02-14 2:15 pm Unchanged | 2020-12-31 | 13G | SAVARA INC SVRA | EcoR1 Capital, LLC | 3,040,540 5.300% | 0 (Unchanged) | Filing History |
| 2022-02-14 2:15 pm Sale | 2021-12-31 | 13G | REGULUS THERAPEUTICS INC RGLS | EcoR1 Capital, LLC | 253,897 1.700% | -111,111 (-30.44%) | Filing History |
| 2022-02-14 1:39 pm Purchase | 2021-12-31 | 13G | GRITSTONE BIO INC GRTSQ | EcoR1 Capital, LLC | 6,319,232 9.300% | 1,384,300 (+28.05%) | Filing History |